Stay updated on LGX818/MEK162 vs Vemurafenib/LGX818 in Melanoma Clinical Trial
Sign up to get notified when there's something new on the LGX818/MEK162 vs Vemurafenib/LGX818 in Melanoma Clinical Trial page.

Latest updates to the LGX818/MEK162 vs Vemurafenib/LGX818 in Melanoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 was added to the history, and the funding-lapse notice and Revision: v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a government funding/status notice and a site revision update from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded the glossary display and color-coded change highlights on the history page, and introduced a new revision label (Revision: v3.4.0) while removing the older label (v3.3.4) and the 'No FEAR Act Data' text.SummaryDifference0.5%

- Check42 days agoChange DetectedThe Version History now lists revision v3.3.4 as the latest update and removes v3.3.3 from the history. This appears to be an administrative update to the record rather than a substantive change to trial information.SummaryDifference0.1%

- Check63 days agoChange DetectedFooter updates show Revision: v3.3.3 and remove the HHS Vulnerability Disclosure link, replacing the previous Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check85 days agoChange DetectedRevision label on the Record History page updated from v3.3.1 to v3.3.2, reflecting a minor system update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to LGX818/MEK162 vs Vemurafenib/LGX818 in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LGX818/MEK162 vs Vemurafenib/LGX818 in Melanoma Clinical Trial page.